Business · 02/05/2002Updated: 10/17/2026 · 1 min read
FDA Dermatologic and Ophthalmic Drugs Advisory Committee to Meet on May 23, 2002
Summary
The FDA is hosting a public meeting of its Dermatologic and Ophthalmic Drugs Advisory Committee, where the committee will discuss a biologic license application with submission tracking number 125036, and provide advice on FDA's regulatory issues.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →